Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 2207-2210, June 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Angello, J. C.
Right arrow Articles by Hosick, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Angello, J. C.
Right arrow Articles by Hosick, H. L.

Glycosaminoglycan Synthesis by Subpopulations of Epithelial Cells from a Mammary Adenocarcinoma1

John C. Angello2, Keith G. Danielson3, Lawrence W. Anderson4 and Howard L. Hosick5

Department of Zoology, Washington State University, Pullman, Washington 99164

Glycosaminoglycan synthesis by two subpopulations of a mouse mammary tumor cell line was compared. The two sublines express distinctly different growth characteristics in vitro and in vivo which indicate differences in growth regulation. Newly made glycosaminoglycans were recovered from the culture media, the cell surfaces, and residual cellular material. The cell population which grows more aggressively in vivo (+SA subline, a subline that grows in soft agarose) incorporated about 8 times more [14C]glucosamine per cell into total glycosaminoglycans than did the slower-growing population (-SA subline, which does not grow in soft agarose). Appropriate control experiments indicated that the apparent difference in rates of synthesis was not due to discrepancies in glucosamine uptake. The main residual cellular molecule labeled was heparan sulfate, but the predominant molecule at the cell surface and in the culture fluid was hyaluronic acid. Overall, +SA cells synthesized more hyaluronic acid and -SA cells synthesized more heparan sulfate; in both cell populations, these two molecules accounted for about 90% of total glycosaminoglycans produced.

1 Supported by NIH Grant CA-16392 and Contract NO1 CB-63986 from the Breast Cancer Task Force of the National Cancer Institute.

2 Present address: Department of Biological Structure, SM-20 University of Washington, Seattle, Wash. 98195.

3 Present address: Department of Biochemistry, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Md. 21205.

4 Recipient of postdoctoral fellowships from NIH (CA05732-01A1) and the American Cancer Society (PF 1472). Present address: Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Wash. 99164.

5 To whom requests for reprints should be addressed.

Received 10/27/81. Accepted 3/ 2/82.




This article has been cited by other articles:


Home page
Cancer Res.Home page
R. Kosaki, K. Watanabe, and Y. Yamaguchi
Overproduction of Hyaluronan by Expression of the Hyaluronan Synthase Has2 Enhances Anchorage-independent Growth and Tumorigenicity
Cancer Res., March 1, 1999; 59(5): 1141 - 1145.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.